| ISIN | LU1169820997 |
|---|---|
| Valor Number | 26749332 |
| Bloomberg Global ID | UKCHF SW |
| Fund Name | UBS (Lux) Fund Solutions – UBS MSCI United Kingdom UCITS ETF hCHF acc |
| Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Asset Management Switzerland AG, Zurich |
| Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
| Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
| Asset Class | Equities |
| EFC Category | Equity United Kingdom |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | The sub-fund aims to track, before expenses, the price and income performance of the price of the MSCI United Kingdom Index (Net Return) (this sub-fund's "Index"). Additionally currency hedged share classes aim to reduce the impact of currency fluctuations between their reference currency and the index currency by selling currency forwards at the one-month forward rate in accordance with the hedging methodology of the Index's currency-hedged index variant. |
| Peculiarities |
| Current Price * | 17.01 CHF | 04.11.2025 |
|---|---|---|
| Previous Price * | 16.97 CHF | 03.11.2025 |
| 52 Week High * | 17.09 CHF | 30.10.2025 |
| 52 Week Low * | 13.67 CHF | 09.04.2025 |
| NAV * | 17.01 CHF | 04.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 3,350,383,410 | |
| Unit/Share Assets *** | 263,604,767 | |
| Trading Information SIX | ||
| YTD Performance | +17.79% |
31.12.2024 - 04.11.2025
31.12.2024 04.11.2025 |
|---|---|---|
| 1 month | +2.23% |
06.10.2025 - 04.11.2025
06.10.2025 04.11.2025 |
| 3 months | +6.27% |
04.08.2025 - 04.11.2025
04.08.2025 04.11.2025 |
| 6 months | +12.05% |
06.05.2025 - 04.11.2025
06.05.2025 04.11.2025 |
| 1 year | +17.27% |
04.11.2024 - 04.11.2025
04.11.2024 04.11.2025 |
| 2 years | +28.70% |
06.11.2023 - 04.11.2025
06.11.2023 04.11.2025 |
| 3 years | +29.80% |
04.11.2022 - 04.11.2025
04.11.2022 04.11.2025 |
| 5 years | +75.46% |
04.11.2020 - 04.11.2025
04.11.2020 04.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AstraZeneca PLC | 8.68% | |
|---|---|---|
| HSBC Holdings PLC | 8.32% | |
| Shell PLC | 7.58% | |
| Unilever PLC | 5.03% | |
| Rolls-Royce Holdings PLC | 4.40% | |
| British American Tobacco PLC | 3.62% | |
| GSK PLC | 3.25% | |
| BP PLC | 3.17% | |
| RELX PLC | 2.76% | |
| Rio Tinto PLC Ordinary Shares | 2.76% | |
| Last data update | 30.10.2025 | |
| TER | 0.23% |
|---|---|
| TER date | 30.06.2024 |
| Performance Fee *** | 0.00% |
| PTR | |
| Max. Management Fee *** | 0.23% |
| Ongoing Charges *** | 0.23% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |